Koers RavenQuest BioMed Inc. Canadian Securities Exchange
Aandelen
RQB
CA7543871080
Bedrijfsondersteunende diensten
Omzet 2017 | 0,11 0,15 0,1 | Omzet 2018 | 1,26 1,72 1,16 | Marktkapitalisatie | 58,71 mln. 80,2 mln. 54,1 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | -3 mln. -4,1 mln. -2,76 mln. | Nettowinst (verlies) 2018 | -30 mln. -40,99 mln. -27,64 mln. | EV/omzet 2017 * | - |
Nettoliquiditeiten 2017 | 3,15 mln. 4,3 mln. 2,9 mln. | Nettoschuld 2018 | 12,9 mln. 17,62 mln. 11,88 mln. | EV/omzet 2018 | 56.975.119 x |
K/w-verhouding 2017 * |
-
| K/w-verhouding 2018 |
-1,55
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 89,48% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jay Dhaliwal
CEO | Chief Executive Officer | 35 | 27-11-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jay Dhaliwal
CEO | Chief Executive Officer | 35 | 27-11-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+12,96% | 7,89 mld. | |
-31,99% | 3,34 mld. | |
+8,88% | 2,76 mld. | |
0,00% | 2,37 mld. | |
-1,62% | 1,56 mld. | |
-8,52% | 1,1 mld. | |
+21,46% | 838 mln. | |
-11,31% | 695 mln. | |
-8,74% | 606 mln. |